Last reviewed: May 12, 2026
Last updated: May 12, 2026
Written by:
Jay Hastings
,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This review is part of the PlexusDx Education Hub, our resource for evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic variables behind every metabolic decision. Browse all Peptides & GLP-1 education
Full head-to-head: PlexusDx vs MEDVi →
This is an independent editorial review. PlexusDx holds no commercial relationship with Medvi or its parent company, and no affiliate links or compensation are involved.
Medvi is one of many telehealth brands operating in the GLP-1 weight-management space, and shoppers usually reach its pages with a single question: what will this actually cost each month? This review breaks down how Medvi’s pricing is built — the promotional first month, the ongoing rate, what the fee covers, and the levers that raise or lower it. Fair-balance editorial framing, not a buying recommendation, current as of April 2026.
Start your GLP-1 program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.
Start your intake →
What Medvi is, in one paragraph
Medvi (Medvi Wellness) runs as a telehealth-plus-compounded-pharmacy program. A licensed provider reviews a virtual intake and, where appropriate, issues a prescription filled through a 503A compounding pharmacy, with follow-up for titration and side effects. For the current program structure and live pricing, see Medvi’s official website.
How Medvi’s pricing is structured
Medvi shows its pricing only after a short health questionnaire, and it is promotion-led. As captured July 2026, compounded semaglutide runs about $299 per month on an ongoing basis after a $159 first-month promotional price, while compounded tirzepatide runs about $399 per month ongoing after a $259 first month. Pricing is flat across dose rather than climbing as you titrate up, and multi-month prepaid bundles bring the effective monthly rate lower. Numbers change frequently, so confirm them at Medvi’s official website before committing.
What the fee includes — and what sits outside it
On the compounded plans there is no separate membership fee and no standalone consultation charge; the monthly price covers the provider evaluation, the medication, and follow-up. Branded Wegovy or Zepbound options sit outside that structure, offered separately at a $99 membership plus the cost of the medication. Medvi also lists a dissolvable GLP-1 tablet, with its price revealed after the intake questionnaire rather than posted upfront.
What drives your cost up or down
Within this model, a handful of factors move the total: whether you choose semaglutide or tirzepatide, whether you prepay for several months or pay month to month, and whether you stay on the compounded plan or step over to a branded product with its membership. Because compounded pricing is flat across dose, titrating to a higher dose does not by itself raise the monthly figure — a meaningful difference from step-up pricing models.
The pharmacology beneath the price
Any legitimate GLP-1 program is only as good as the pharmacology underneath it: GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and GIP/GLP-1 dual agonists (tirzepatide). The anchor trials are STEP (semaglutide for weight management, The New England Journal of Medicine, 2021), SURMOUNT (tirzepatide for weight management, NEJM 2022), and SURMOUNT-OSA (tirzepatide for obstructive sleep apnea, NEJM 2024). Trial populations and endpoints differ, and individual outcomes vary.
The cost input no telehealth quote captures
Every price above buys the compound and the visit — none of it accounts for the genetic architecture that shapes how you respond. Variants in FTO (the fat-mass and obesity-associated gene), GLP1R (the GLP-1 receptor gene that every GLP-1 compound targets), MC4R (a melanocortin receptor central to satiety), and TCF7L2 (a transcription factor tied to glucose homeostasis and GLP-1 secretion) map the metabolic terrain a clinician is prescribing into. They are pathway-level and do not predict response to any specific compound, but they describe biology a flat monthly quote never sees.
PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols — available as Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral. The differentiator is that upstream context. Before any GLP-1 protocol begins, the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights — including the FTO, GLP1R, MC4R, and TCF7L2 variants that shape your baseline appetite, energy-balance, and GLP-1 biology. Pairing that profile with the protocol is the test before you invest approach — turning guesswork into an informed conversation with your provider.
Not affiliated: PlexusDx is not affiliated with Medvi and has no commercial relationship with the companies reviewed in this article.
Related reading on PlexusDx: What Is GLP 1, GLP 1 What Is, GLP 1 Receptor Agonist, GLP 1 Drugs.
Disclaimer: This article is educational. PlexusDx is not affiliated with Medvi and has no commercial relationship with the companies reviewed. PlexusDx offers semaglutide and tirzepatide through its own Weight Management Protocols, and this review compares approaches in the GLP-1 telehealth space. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways — it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.
Compare the PlexusDx approach: see the Weight Management Protocols — semaglutide and tirzepatide with the genetic context most telehealth programs skip. Or start upstream: take the Precision Peptide Genetic Test to understand your GLP-1 pathway first.
Frequently Asked Questions
How much does Medvi cost per month?
As captured July 2026, compounded semaglutide is about $299 per month ongoing after a $159 first month, and compounded tirzepatide about $399 per month ongoing after a $259 first month. Pricing is flat across dose, and prepaid multi-month bundles lower the effective monthly rate. Confirm current numbers on Medvi’s own site.
Does Medvi charge a membership or consultation fee?
On the compounded plans, no — the monthly price covers the evaluation, medication, and follow-up with no separate membership or consultation charge. The branded Wegovy and Zepbound routes are different, adding a $99 membership plus the cost of the medication. The dissolvable GLP-1 tablet’s price appears after intake.
Does the dose affect the price?
On Medvi’s compounded plans, pricing is flat across dose, so titrating to a higher dose does not by itself raise your monthly cost. What changes the total is the compound you choose, whether you prepay for multiple months, and whether you move to a branded product with its membership fee.
Does the Precision Peptide Genetic Test change what I pay Medvi?
No. The test is a separate PlexusDx product and does not predict response to any telehealth program or compound. It analyzes pathway-level variants in FTO, GLP1R, MC4R, and TCF7L2 that shape baseline GLP-1 biology — upstream context that applies no matter which service writes the prescription.
This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
MaxLife Weight Loss Program: Medications and Provider Model
MaxLife Weight Loss Program: Medications and Provider Model